Larry Biegelsen
Stock Analyst at Wells Fargo
(3.91)
# 528
Out of 4,829 analysts
305
Total ratings
53.81%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $113 → $98 | $95.21 | +2.93% | 10 | May 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $195 → $174 | $151.25 | +15.04% | 12 | May 6, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $146 → $137 | $125.11 | +9.50% | 5 | May 2, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $36 → $33 | $30.90 | +6.80% | 16 | May 2, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $15 → $12 | $11.27 | +6.48% | 6 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $103 → $89 | $69.87 | +27.38% | 4 | May 1, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $22 → $20 | $22.98 | -12.97% | 9 | May 1, 2025 | |
| GKOS Glaukos | Downgrades: Equal-Weight | $160 → $86 | $89.96 | -4.40% | 14 | May 1, 2025 | |
| PEN Penumbra | Maintains: Overweight | $305 → $315 | $297.32 | +5.95% | 18 | Apr 24, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $22 → $17 | $13.06 | +30.17% | 12 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $22.68 | +23.48% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1.1 → $1.29 | $0.74 | +73.39% | 4 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $117 | $95.83 | +22.09% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $118 | $102.86 | +14.72% | 13 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $12.95 | +31.32% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $427 → $435 | $380.92 | +14.20% | 15 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $630 → $687 | $536.51 | +28.05% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $154.22 | -1.44% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $3.37 | +137.39% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $84.67 | +11.02% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $118 | $82.26 | +43.45% | 16 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $83.48 | +17.39% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $73.68 | +8.58% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $95.75 | +9.66% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $17.38 | +130.15% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $12.25 | +300.00% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $133.24 | +2.07% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $55.82 | +25.40% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $167.22 | +61.46% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $81.74 | - | 2 | Nov 2, 2017 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $95.21
Upside: +2.93%
Inspire Medical Systems
May 6, 2025
Maintains: Equal-Weight
Price Target: $195 → $174
Current: $151.25
Upside: +15.04%
Teleflex
May 2, 2025
Maintains: Equal-Weight
Price Target: $146 → $137
Current: $125.11
Upside: +9.50%
Baxter International
May 2, 2025
Maintains: Equal-Weight
Price Target: $36 → $33
Current: $30.90
Upside: +6.80%
Bausch + Lomb
May 1, 2025
Maintains: Equal-Weight
Price Target: $15 → $12
Current: $11.27
Upside: +6.48%
GE HealthCare Technologies
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $69.87
Upside: +27.38%
Tandem Diabetes Care
May 1, 2025
Maintains: Equal-Weight
Price Target: $22 → $20
Current: $22.98
Upside: -12.97%
Glaukos
May 1, 2025
Downgrades: Equal-Weight
Price Target: $160 → $86
Current: $89.96
Upside: -4.40%
Penumbra
Apr 24, 2025
Maintains: Overweight
Price Target: $305 → $315
Current: $297.32
Upside: +5.95%
RxSight
Apr 7, 2025
Maintains: Equal-Weight
Price Target: $22 → $17
Current: $13.06
Upside: +30.17%
Mar 31, 2025
Initiates: Overweight
Price Target: $28
Current: $22.68
Upside: +23.48%
Mar 18, 2025
Maintains: Equal-Weight
Price Target: $1.1 → $1.29
Current: $0.74
Upside: +73.39%
Feb 26, 2025
Maintains: Overweight
Price Target: $120 → $117
Current: $95.83
Upside: +22.09%
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $118
Current: $102.86
Upside: +14.72%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $12.95
Upside: +31.32%
Jan 29, 2025
Maintains: Overweight
Price Target: $427 → $435
Current: $380.92
Upside: +14.20%
Jan 24, 2025
Maintains: Overweight
Price Target: $630 → $687
Current: $536.51
Upside: +28.05%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $154.22
Upside: -1.44%
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $3.37
Upside: +137.39%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $84.67
Upside: +11.02%
Dec 6, 2024
Maintains: Overweight
Price Target: $115 → $118
Current: $82.26
Upside: +43.45%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $83.48
Upside: +17.39%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $73.68
Upside: +8.58%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $95.75
Upside: +9.66%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $17.38
Upside: +130.15%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $12.25
Upside: +300.00%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $133.24
Upside: +2.07%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $55.82
Upside: +25.40%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $167.22
Upside: +61.46%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $81.74
Upside: -